Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 3/2009

01-03-2009 | Original Article

Progression of coronary calcification in pediatric chronic kidney disease stage 5

Authors: Mahmut Civilibal, Salim Caliskan, Sebuh Kurugoglu, Cengiz Candan, Nur Canpolat, Lale Sever, Ozgur Kasapcopur, Nil Arisoy

Published in: Pediatric Nephrology | Issue 3/2009

Login to get access

Abstract

Coronary artery calcification (CAC) is common in adults with chronic kidney disease (CKD) and progresses with time. However, data are limited for younger patients. We have previously reported CAC in eight of 53 children with CKD. After 2 years, CAC evaluation was repeated in 48 patients. The median CAC score (CACS) increased from 101.3 (1473.6 ± 1978.6, range 8.5–4332) to 1759.2 (2236.4 ± 2463.3, range 0–5858) Agatston units (AU). When the individual changes in CACS were evaluated one by one, we showed a mild decrease in two patients on hemodialysis (HD) and in one transplant (Tx) recipient, a moderate increase in one patient on HD, one on peritoneal dialysis (PD) and one Tx recipient, and a large increase in one HD patient. Also, CAC disappeared in one HD patient. All patients with no calcification at baseline remained calcification-free at follow-up. To obtain the individual cumulative exposure, we calculated time-averaged mean values, using the laboratory values from the beginning of dialysis to the first and second multidetector spiral computed tomography (MDCT) scans (baseline and final values, respectively). Final CACS was positively related to final calcium–phosphorus (Ca×P) product, while CAC progression was inversely associated with final serum albumin level. This report is the first study with the largest number and the youngest cohort to document the natural history of coronary calcification.
Literature
1.
Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 [Suppl 12]:S16–S23PubMed
2.
Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 432:1478–1483
3.
Eifinger F, Wahn F, Querfeld U, Pollok M, Gevargez A, Kriener P, Grönemeyer D (2000) Coronary artery calcifications in children and young adults treated with renal replacement therapy. Nephrol Dial Transplant 15:1892–1894PubMed
4.
Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100–105PubMed
5.
Briese S, Wiesner S, Will JC, Lembcke A, Opgen-Rhein B, Nissel R, Wernecke KD, Andreae J, Haffner D, Querfeld U (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906–1914CrossRefPubMed
6.
Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996–3003PubMed
7.
Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426–1433PubMed
8.
Moe SM, O’Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA (2004) Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 19:2387–2393PubMed
9.
Stompor T, Pasowicz M, Sulowicz W, Dembinska-Kiec A, Tracz W (2004) Trends in coronary artery calcification in peritoneal dialysis and transplant patients. Nephrol Dial Transplant 19:3205–3206PubMed
10.
Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64–69PubMed
11.
Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245–252PubMed
12.
Asmus HG, Braun J, Krause R, Brunkhorst R, Holzer H, Schulz W, Neumayer HH, Raggi P, Bommer J (2005) Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 20:1653–1661PubMed
13.
Jung HH, Kim SW, Han H (2006) Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 21:1915–1920PubMed
14.
Yuen D, Pierratos A, Richardson RM, Chan CT (2006) The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 21:1407–1412PubMed
15.
De Lima JJ, Vieira ML, Viviani LF, Medeiros CJ, Ianhez LE, Kopel L, de Andrade JL, Krieger EM, Lage SG (2002) Long-term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 17:645–651PubMed
16.
Litwin M, Wühl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F (2008) Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552–2557PubMed
17.
Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O (2006) Body mass index references for Turkish children. Acta Paediatr 95:194–198PubMed
18.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832PubMed
19.
London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731–1740PubMed
20.
Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S (2004) Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8:54–58PubMed
21.
22.
Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20:760–767PubMed
23.
Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA (2004) Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19:2307–2312PubMed
24.
Moe SM, O’Neill KD, Fineberg N, Persohn S, Ahmed S, Garret P, Meyer CA (2003) Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 18:1152–1158PubMed
25.
Qunibi WY (2005) Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. J Am Soc Nephrol 16 [Suppl 2]:S95–S102PubMed
26.
Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N, Vascular Calcification Work Group (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43:572–579PubMed
27.
Salusky IB, Goodman WG (2000) Managing phosphate retention: is a change necessary? Nephrol Dial Transplant 15:1738–1742PubMed
28.
Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931–936PubMed
29.
Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263–3271PubMed
30.
Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494–1500PubMed
31.
Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179–184PubMed
32.
Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115–1125PubMed
33.
Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858–1865PubMed
34.
Tentori F (2007) Focus on vitamin D therapy in chronic kidney disease. J Nephrol 20:511–514PubMed
35.
Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446–456PubMed
36.
Wolf M, Thadhani R (2007) Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. J Steroid Biochem Mol Biol 103:487–490PubMedPubMedCentral
37.
London GM, Guerin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Metivier F (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613–620PubMed
38.
Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239–1246PubMedPubMedCentral
39.
McCullough PA (2005) Effect of lipid modification on progression of coronary calcification. J Am Soc Nephrol 16 [Suppl 2]:S115–S119PubMed
40.
Chertow GM (2003) Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 14 [Suppl 4]:S310–S314PubMed
41.
Oschatz E, Benesch T, Kodras K, Hoffmann U, Haas M (2006) Changes of coronary calcification after kidney transplantation. Am J Kidney Dis 48:307–313PubMed
42.
Schankel K, Robinson J, Bloom RD, Guerra C, Rader D, Joffe M, Rosas SE (2007) Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant 7:2158–2164PubMed
43.
Ligtenberg G, Hene RJ, Blankestijn PJ, Koomans HA (2001) Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus. J Am Soc Nephrol 12:368–373PubMed
44.
Oflaz H, Turkmen A, Kazancioglu R, Kayacan SM, Bunyak B, Genchallac H, Erol B, Mercanoglu F, Umman S, Sever MS (2003) The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 17:212–216PubMed
45.
Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Vos PF, Blom HJ, Sweep FC, Demacker PN, Hilbrands LB (2003) Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus. J Am Soc Nephrol 14:1880–1888PubMed
46.
Schmermund A, Baumgart D, Möhlenkamp S, Kriener P, Pump H, Grönemeyer D, Seibel R, Erbel R (2001) Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 21:421–426PubMed
47.
Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339:1972–1978PubMed
48.
Sigrist MK, Taal MW, Bungay P, McIntyre CW (2007) Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2:1241–1248PubMed
49.
Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK (2004) Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489–1496PubMed
50.
Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y (2004) Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. Am J Clin Nutr 80:1536–1543PubMed
51.
Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936PubMed
52.
Stompor T, Pasowicz M, Sullowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203–211PubMed
53.
Tonbul HZ, Demir M, Altintepe L, Güney I, Yeter E, Türk S, Yeksan M, Yildiz A (2006) Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail 28:287–294PubMed
54.
Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, Gullulu M (2008) Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 108:99–105
Metadata
Title
Progression of coronary calcification in pediatric chronic kidney disease stage 5
Authors
Mahmut Civilibal
Salim Caliskan
Sebuh Kurugoglu
Cengiz Candan
Nur Canpolat
Lale Sever
Ozgur Kasapcopur
Nil Arisoy
Publication date
01-03-2009
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 3/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-1038-0

Other articles of this Issue 3/2009

Pediatric Nephrology 3/2009 Go to the issue

Brief Report

Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates

Original Article

Hyponatremia due to an excess of arginine vasopressin is common in children with febrile disease

Original Article

Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants

Original Article

Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine

Brief Report

Reevaluation of glomerular charge selective protein-sieving function

Brief Report

Exercise training in pediatric patients with end-stage renal disease